KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) EBT Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed EBT Margin for 9 consecutive years, with 29.18% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 633.0% to 29.18% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 19.33% through Dec 2025, up 4026.0% year-over-year, with the annual reading at 20.43% for FY2025, 4608.0% up from the prior year.
  • EBT Margin for Q4 2025 was 29.18% at Twist Bioscience, down from 27.15% in the prior quarter.
  • The five-year high for EBT Margin was 21.43% in Q2 2025, with the low at 133.2% in Q4 2021.
  • Average EBT Margin over 5 years is 75.88%, with a median of 82.83% recorded in 2022.
  • The sharpest move saw EBT Margin plummeted -3360bps in 2021, then surged 12623bps in 2025.
  • Over 5 years, EBT Margin stood at 133.2% in 2021, then soared by 42bps to 76.96% in 2022, then grew by 22bps to 59.98% in 2023, then surged by 41bps to 35.5% in 2024, then increased by 18bps to 29.18% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 29.18%, 27.15%, and 21.43% for Q4 2025, Q3 2025, and Q2 2025 respectively.